Pharmaco-epidemiologic study of the prescription of contraindicated drugs in a primary care setting of a university: A retrospective review of drug prescription

International Journal of Clinical Pharmacology and Therapeutics

Volumn 49, Issue 8, 2011, Pages 500-509

  Dhabali, A A H ^a   Awang, R ^a   Zyoud, S H ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Drug contraindications; Malaysia; Medication errors; Prevalence; Primary care setting

Indexed keywords

CELECOXIB; DICLOFENAC; DILTIAZEM; DIPHENHYDRAMINE; DIPHENOXYLATE; ERGOTAMINE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INDOMETACIN; LOPERAMIDE; MEFENAMIC ACID; METFORMIN; NAPROXEN; NIFEDIPINE; PROPRANOLOL; ROSIGLITAZONE; SCOPOLAMINE BUTYL BROMIDE;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EXPOSURE; FEMALE; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICATION ERROR; PHARMACOEPIDEMIOLOGY; PREVALENCE; PRIMARY MEDICAL CARE; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; DATABASES, FACTUAL; FEMALE; HEALTH STATUS; HUMANS; LOGISTIC MODELS; MALAYSIA; MALE; MEDICATION ERRORS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHARMACEUTICAL PREPARATIONS; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; UNIVERSITIES; YOUNG ADULT;

EID: 80052186897     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201524     Document Type: Article

References (39)

1. Radosević N, Gantumur M, Vlahović-Palcevski V. Potentially inappropriate prescribing to hospitalised patients. Pharmacoepidemiol Drug Saf. 2008; 17: 733-737. doi:10.1002/pds.1531 PubMed
2. Zhan C, Correa-de-Araujo R, Bierman AS, Sangl J, Miller MR, Wickizer SW, Stryer D. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drag and drug-disease combinations. J Am Geriatr Soc. 2005; 53: 262-267. doi:10.1111/j.1532-5415.2005.53112.x PubMed
3. Gorard DA. Escalating polypharmacy. QJM. 2006; 99: 797-800. doi:10.1093/qjmed/hcl109 PubMed
4. Lindblad CI, Artz MB, Pieper CF, Sloane RJ, Hajjar ER, Ruby CM, Schmader KE, Hanlon JT. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother. 2005; 39: 412-417. doi:10.1345/aph.1E467 PubMed
5. Lindblad CI, Hanlon JT, Gross CR, Sloane RJ, Pieper CF, Hajjar ER, Ruby CM, Schmader KE, Multidisciplinaryconsensuspanel. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther. 2006; 28: 1133-1143. doi:10.1016/j.clinthera.2006.08.006 PubMed
6. Fillenbaum GG, Hanlon JT, Landerman LR, Artz MB, O'Connor H, Dowd B, Gross CR, Boult C, Garrard J, Schmader KE. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother. 2004; 2: 92-101. doi:10.1016/S1543- 5946(04)90014-1 PubMed (Pubitemid 39060758)
7. Hanlon JT, Fillenbaum GG, Kuchibhatla M, Artz MB, Boult C, Gross CR, Garrard J, Schmader KE. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care. 2002; 40: 166-176. doi: 10.1097/00005650-200202000-00011 PubMed
8. Peyriere H, Cassan S, Floutard E, Riviere S, Blayac JP, Hillaire-Buys D, Le Quellec A, Hansel S. Adverse drug events associated with hospital admission. Ann Pharmacother. 2003; 37: 5-11. doi:10.1345/aph.1C126 PubMed
9. Lindblad CIG, Guay DR, et al. Geriatrics. In: Dipiro IT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York, NY: McGraw-Hill. 2005: 103-113.
10. Brvar M, Fokter N, Bunc M, Mozina M. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol. 2009; 9: 8 doi:10.1186/1472-6904-9-8 PubMed
11. Doubova SV, Reyes-Morales H, Torres-Arreola Ldel P, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007; 7: 147 PubMed doi: 10.1186/1472-6963-7-147
12. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet. 1984; 2: 564-567. doi:10.1016/S0140-6736(84)90775-X PubMed (Pubitemid 14072066)
13. Chen YF, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH. Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice. Drug Saf. 2005; 28: 67-80. doi: 10.2165/00002018-200528010-00005 PubMed
14. Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G. Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996; 49: 255-259. doi:10.1007/BF00226324 PubMed
15. Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing. 1997; 26: 375-382. doi:10. 1093/ageing/26.5.375 PubMed (Pubitemid 27448382)
16. Vinks TH, de Koning FH, de Lange TM, Egberts TC. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci. 2006; 28: 33-38. doi:10.1007/S11096-005-4213-4 PubMed (Pubitemid 44198336)
17. Vinks TH, Egberts TC, de Lange TM, de Koning FH. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009; 26: 123-133. doi: 10.2165/0002512- 20092602000004 PubMed
18. Freestone B, Rajaratnam R, Hussain N, Lip GY. Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia. Int J Cardiol. 2003; 91: 233-238. doi:10.1016/S01675273(03)00031-7 PubMed
19. Amir O, Hassan Y, Sarriff A, Awaisu A, Abd Aziz N, Ismail O. Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases. Pharm World Sci. 2009; 31: 387-393. PubMed doi:10.1007/s11096009-9288-x
20. Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother. 2009; 43: 1598-1605. doi:10.1345/aph.1M187 PubMed
21. Dhabali AA, Awang R. A medication-estimated health status measure for predicting primary care visits: the Long-Term Therapeutic Groups Index. Health Policy Plan. 2010; 25: 162-169. doi:10.1093/heapol/czp051 PubMed
22. Koda-Kimble M. Applied Therapeutics: The Clinical Use of Drugs. Lippincott Williams & Wilkins. 2004.
23. Aronson J. Meyler's Side Effects of Drugs, 15th ed.: The International Encyclopedia of Adverse Drug Reactions and Interactions. New York: Elsevier; 2006.
24. McEvoy GKMJ, Snow EK, Welsh OH, Litvak K. In: McEvoy GK, Miller J, Snow EK, Welsh OH, Litvak K, eds. American Hospital (AHFS) drug information; 2004.
25. Anderson P. Handbook of Clinical Drug Data. New York: McGraw-Hill Medical Publishing; 2001.
26. Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists' medication review recommendations. Pharm World Sci. 2003; 25: 212-217. doi:10.1023/A:1025860615268 PubMed
27. Gómez MA, Villafaina A, Hernández J, Salgado RM, González MA, Rodríguez J, Martínez de la Concha M, Tarriño A, Gervasini G, Carrillo JA. Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting. Ann Pharmacother. 2009; 43: 339-346. PubMed
28. Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, Rasmussen M. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009; 31: 216-223. doi: 10.1007/s11096-009-9287-y PubMed
29. Sauer BC, Hepler CD, Cherney B, Williamson J. Computerized indicators of potential drug-related emergency department and hospital admissions. Am J Manag Care. 2007; 13: 29-35. PubMed
30. Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, Wilbur K, Wiens MO, Samoy LJ, Lacaria K, Purssell RA. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ. 2008; 178: 1563-1569. doi:10.1503/cmaj.071594 PubMed
31. WHO. The treatment of diarrhea: a manual for physicians and other senior health workers. Geneva: World Health Organization; 2005.
32. Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Am J Gastroenterol. 2001; 96: 1019-1027. doi:10.1111/j.1572-0241.2001.03740.x PubMed
33. Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Clin Ther. 2006; 28: 340-351. doi:10.1016/j.clinthera. 2006.03.007 PubMed (Pubitemid 43783437)
34. Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford). 2003; 42 (Suppl 3): iii23-iii31. doi:10.1093/ rheumatology/keq495 PubMed
35. Lanza FL; Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol. 1998; 93: 2037-2046. doi: 10.1111/j.1572-0241.1998.00588.x PubMed
36. Schnitzer TJ, Kong SX, Mavros PP, Straus WL, Watson DJ. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database. Clin Ther. 2001; 23: 1984-1998. doi:10.1016/S0149- 2918(01)80151-X PubMed
37. Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, Frank C, Klarenbach S, Hemmelgarn BR. NSAID use and progression of chronic kidney disease. Am J Med. 2007; 120: 280 e281-287.
38. Aronoff A, Barkum H. Hyperuricemia and acute gouty arthritis precipitated by thiazide derivatives. Can Med Assoc J. 1961; 84: 1181-1186. PubMed
39. Spieker LE, Ruschitzka FT, Lüscher TF, Noll G The management of hyperuricemia and gout in patients with heart failure. Eur J Heart Fail. 2002; 4: 403-410. doi:10.1016/S1388-9842(02)00 086-7 PubMed